Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 3567275, 13 pages
http://dx.doi.org/10.1155/2016/3567275
Research Article

Effect of Erythropoietin on Postresuscitation Renal Function in a Swine Model of Ventricular Fibrillation

1Department of Anaesthetics, Liver Transplant Unit, King’s College Hospital, London, UK
2Neonatology Department, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
3Department of Biopathology, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
4MSc “Cardiopulmonary Resuscitation”, Medical School, National and Kapodistrian University of Athens, Athens, Greece
5ELPEN Research-Experimental Centre, Athens, Greece
62nd Department of Surgery, Medical School, National and Kapodistrian University of Athens, Athens, Greece
7Division of Pathology, Department of Surgical Sciences, University of Cagliari Medical School, Cagliari, Italy
8School of Medicine, European University Cyprus, Nicosia, Cyprus

Received 19 July 2016; Revised 13 September 2016; Accepted 21 September 2016

Academic Editor: Hideo Inaba

Copyright © 2016 Charalampos Pantazopoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Lameire, W. Van Biesen, and R. Vanholder, “Acute renal failure,” The Lancet, vol. 365, no. 9457, pp. 417–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Devarajan, “Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 68, no. 241, pp. 89–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. C. R. Parikh, J. Mishra, H. Thiessen-Philbrook et al., “Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery,” Kidney International, vol. 70, no. 1, pp. 199–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Portilla, C. Dent, T. Sugaya et al., “Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery,” Kidney International, vol. 73, no. 4, pp. 465–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Sato, T. Maekawa, S. Watanabe, K. Tsuji, and T. Nakahata, “Erythroid progenitors differentiate and mature in response to endogenous erythropoietin,” The Journal of Clinical Investigation, vol. 106, no. 2, pp. 263–270, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. N. P. Riksen, D. J. Hausenloy, and D. M. Yellon, “Erythropoietin: ready for prime-time cardioprotection,” Trends in Pharmacological Sciences, vol. 29, no. 5, pp. 258–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Maiese, F. Li, and Z. Z. Chong, “Erythropoietin in the brain: can the promise to protect be fulfilled?” Trends in Pharmacological Sciences, vol. 25, no. 11, pp. 577–583, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Depping, K. Kawakami, H. Ocker et al., “Expression of the erythropoietin receptor in human heart,” The Journal of Thoracic and Cardiovascular Surgery, vol. 130, no. 3, pp. 877.e1–877.e4, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Xanthos, E. Bassiakou, E. Koudouna et al., “Baseline hemodynamics in anesthetized Landrace-Large White swine: reference values for research in cardiac arrest and cardiopulmonary resuscitation models,” Journal of the American Association for Laboratory Animal Science, vol. 46, no. 5, pp. 21–25, 2007. View at Google Scholar · View at Scopus
  10. T. Xanthos, E. Bassiakou, E. Koudouna et al., “Combination pharmacotherapy in the treatment of experimental cardiac arrest,” The American Journal of Emergency Medicine, vol. 27, no. 6, pp. 651–659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Nolan, J. Soar, D. A. Zideman et al., “European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary,” Resuscitation, vol. 81, no. 10, pp. 1219–1276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Xanthos, P. Lelovas, I. Vlachos et al., “Cardiopulmonary arrest and resuscitation in Landrace/Large White swine: a research model,” Laboratory Animals, vol. 41, no. 3, pp. 353–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Fanni, V. Fanos, C. Gerosa et al., “Acute kidney injury in the newborn: the role of the perinatal pathologist,” Journal of Pediatric and Neonatal Individualized Medicine, vol. 3, no. 2, Article ID e030262, 2014. View at Google Scholar
  14. H.-R. Chua, N. Glassford, and R. Bellomo, “Acute kidney injury after cardiac arrest,” Resuscitation, vol. 83, no. 6, pp. 721–727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Geri, L. Guillemet, F. Dumas et al., “Acute kidney injury after out-of-hospital cardiac arrest: risk factors and prognosis in a large cohort,” Intensive Care Medicine, vol. 41, no. 7, pp. 1273–1280, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Mei, C.-C. Hang, S. Wang, C.-S. Li, and Z.-X. Yu, “Renal doppler and novel biomarkers to assess acute kidney injury in a swine model of ventricular fibrillation cardiac arrest,” Chinese Medical Journal, vol. 128, no. 22, pp. 3069–3075, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. W. Kim, K. C. Cha, Y. S. Cha et al., “Shock duration after resuscitation is associated with occurrence of post-cardiac arrest acute kidney injury,” Journal of Korean Medical Science, vol. 30, no. 6, pp. 802–807, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Tujjar, G. Mineo, A. Dell'Anna et al., “Acute kidney injury after cardiac arrest,” Critical Care, vol. 19, no. 1, article 169, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Hasper, S. von Haehling, C. Storm, A. Jörres, and J. C. Schefold, “Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study,” Critical Care, vol. 13, no. 5, article R168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Domanovits, M. Müllner, F. Sterz et al., “Impairment of renal function in patients resuscitated from cardiac arrest: frequency, determinants and impact on outcome,” Wiener Klinische Wochenschrift, vol. 112, no. 4, pp. 157–161, 2000. View at Google Scholar · View at Scopus
  21. C.-C. Hang, C.-S. Li, C.-J. Wu, and J. Yang, “Acute kidney injury after cardiac arrest of ventricular fibrillation and asphyxiation swine model,” American Journal of Emergency Medicine, vol. 32, no. 3, pp. 208–215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Sanchis-Gomar, J. L. Garcia-Gimenez, H. Pareja-Galeano, M. Romagnoli, C. Perez-Quilis, and G. Lippi, “Erythropoietin and the heart: physiological effects and the therapeutic perspective,” International Journal of Cardiology, vol. 171, no. 2, pp. 116–125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, L. Wang, S. Dey et al., “Erythropoietin action in stress response, tissue maintenance and metabolism,” International Journal of Molecular Sciences, vol. 15, no. 6, pp. 10296–10333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. P. V. S. Vasileiou, T. Xanthos, D. Barouxis et al., “Erythropoietin administration facilitates return of spontaneous circulation and improves survival in a pig model of cardiac arrest,” The American Journal of Emergency Medicine, vol. 32, no. 8, pp. 871–877, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. Š. Grmec, M. Strnad, D. Kupnik, A. Sinkovič, and R. J. Gazmuri, “Erythropoietin facilitates the return of spontaneous circulation and survival in victims of out-of-hospital cardiac arrest,” Resuscitation, vol. 80, no. 6, pp. 631–637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Borovnik-Lesjak, K. Whitehouse, A. Baetiong, B. Artin, J. Radhakrishnan, and R. J. Gazmuri, “High-dose erythropoietin during cardiac resuscitation lessens postresuscitation myocardial stunning in swine,” Translational Research, vol. 162, no. 2, pp. 110–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Lundby and N. V. Olsen, “Effects of recombinant human erythropoietin in normal humans,” The Journal of Physiology, vol. 589, no. 6, pp. 1265–1271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Lundby, J. J. Thomsen, R. Boushel et al., “Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume,” Journal of Physiology, vol. 578, no. 1, pp. 309–314, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. N. V. Olsen, N. J. Aachmann-Andersen, P. Oturai et al., “Recombinant human erythropoietin in humans down-regulates proximal renal tubular reabsorption and causes a fall in glomerular filtration rate,” The Journal of Physiology, vol. 589, pp. 1273–1281, 2010. View at Google Scholar
  30. M. Brines and A. Cerami, “Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response,” Journal of Internal Medicine, vol. 264, no. 5, pp. 405–432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Chalkias and T. Xanthos, “Pathophysiology and pathogenesis of post-resuscitation myocardial stunning,” Heart Failure Reviews, vol. 17, no. 1, pp. 117–128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Chalkias and T. Xanthos, “Post-cardiac arrest brain injury: pathophysiology and treatment,” Journal of the Neurological Sciences, vol. 315, no. 1-2, pp. 1–8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Chalkias and T. Xanthos, “Post-cardiac arrest syndrome: mechanisms and evaluation of adrenal insufficiency,” World Journal of Critical Care Medicine, vol. 1, no. 1, pp. 4–9, 2012. View at Publisher · View at Google Scholar
  34. T. Xanthos, P. V. S. Vasileiou, S. Kakavas, A. Syggelou, and N. Iacovidou, “The potential role of erythropoietin as a pleiotropic agent in post-cardiac arrest syndrome,” Current Pharmaceutical Design, vol. 17, no. 15, pp. 1517–1529, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Solez, L. Morel-Maroger, and J. Sauer, “The morphology of acute tubular necrosis in man. Analysis of 57 renal biopsies and comparison with the glycerol model,” Medicine, vol. 58, pp. 362–376, 1979. View at Google Scholar
  36. S. P. Kelleher, J. B. Robinette, F. Miller, and J. D. Conger, “Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure,” Kidney International, vol. 31, no. 3, pp. 725–730, 1987. View at Publisher · View at Google Scholar · View at Scopus
  37. D. W. Johnson, D. A. Vesey, and G. C. Gobe, “Erythropoietin protects against acute kidney injury and failure,” Open Drug Discovery Journal, vol. 2, no. 1, pp. 8–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Kuriyama, H. Tomonari, H. Yoshida, T. Hashimoto, Y. Kawaguchi, and O. Sakai, “Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients,” Nephron, vol. 77, no. 2, pp. 176–185, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. D. A. Vesey, C. Cheung, B. Pat, Z. Endre, G. Gobé, and D. W. Johnson, “Erythropoietin protects against ischaemic acute renal injury,” Nephrology Dialysis Transplantation, vol. 19, no. 2, pp. 348–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. E. J. Sharples, N. Patel, P. Brown et al., “Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2115–2124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Pat, M. D. Hughson, J. L. Nicol, W. E. Hoy, and G. C. Gobe, “A comparison of pathomolecular markers of fibrosis and morphology in kidney from autopsies of African Americans and whites,” Virchows Archiv, vol. 450, no. 1, pp. 41–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Mårtensson, C.-R. Martling, and M. Bell, “Novel biomarkers of acute kidney injury and failure: clinical applicability,” British Journal of Anaesthesia, vol. 109, no. 6, pp. 843–850, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. W. Pickering, A. M. Ralib, and Z. H. Endre, “Combining creatinine and volume kinetics identifies missed cases of acute kidney injury following cardiac arrest,” Critical Care, vol. 17, no. 1, article R7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Elmer, K. Jeong, K. Z. Abebe et al., “Serum neutrophil gelatinase-associated lipocalin predicts survival after resuscitation from cardiac arrest,” Critical Care Medicine, vol. 44, no. 1, pp. 111–119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Matsui, A. Kamijo-Ikemori, T. Sugaya, T. Yasuda, and K. Kimura, “Usefulness of urinary biomarkers in early detection of acute kidney injury after cardiac surgery in adults,” Circulation Journal, vol. 76, no. 1, pp. 213–220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Ronco, D. Cruz, and B. W. Noland, “Neutrophil Gelatinase-Associated Lipocalin Curve and Neutrophil Gelatinase-Associated Lipocalin Extended-Range Assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome,” Seminars in Nephrology, vol. 32, no. 1, pp. 121–128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Wu, M. L. Craft, P. Wang et al., “IL-18 Contributes to renal damage after ischemia-reperfusion,” Journal of the American Society of Nephrology, vol. 19, no. 12, pp. 2331–2341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Lin, J. Yuan, Y. Zhao, and Y. Zha, “Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis,” Journal of Nephrology, vol. 28, no. 1, pp. 7–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Obermüller, H. Geiger, C. Weipert, and A. Urbschat, “Current developments in early diagnosis of acute kidney injury,” International Urology and Nephrology, vol. 46, no. 1, pp. 1–7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Torregrosa, C. Montoliu, A. Urios et al., “Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography,” Heart and Vessels, vol. 30, no. 6, pp. 703–711, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Negishi, E. Noiri, R. Maeda et al., “A sensitive biomarker of AKI: monitoring of urinary L-type fatty acid binding protein (L-FABP),” Journal of the American Society of Nephrology, vol. S18, p. S643A, 2007. View at Google Scholar
  52. E. Noiri, K. Doi, K. Negishi et al., “Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury,” American Journal of Physiology—Renal Physiology, vol. 296, no. 4, pp. F669–F679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Yamamoto, E. Noiri, Y. Ono et al., “Renal L-type fatty acid-binding protein in acute ischemic injury,” Journal of the American Society of Nephrology, vol. 18, no. 11, pp. 2894–2902, 2007. View at Publisher · View at Google Scholar · View at Scopus